Rapid Micro Biosystems, which provides an automated microbial testing device and platform, raised $158 million by offering 7.9 million shares at $20, the high end of the range of $18 to $20. The ...
Microbial testing laboratories often face challenges such as genetic drift, variability in results, and the need for extensive preparation. These issues can lead to inconsistent results and increased ...
Proceeds will enable the company to meet growing demand for its automated microbial detection platform, currently used by a majority of the top 20 global biopharmaceutical companies, and support new ...
DUBLIN--(BUSINESS WIRE)--The "Rapid Microbiology Testing Market by Method (Growth, Viability), Product (Automated Microbial Identification & AST System, PCR, Reagent ...
Paris-based Spore.Bio, a startup that developed an artificial intelligence-driven method for detecting pathogens, said today it has raised $23 million in early-stage funding to reinvent microbiology ...
Please provide your email address to receive an email when new articles are posted on . The appropriate use of antimicrobials in health care continues to be a daunting challenge. While there is no ...
ReportsnReports.com adds the global clinical microbiology market is projected to reach USD 4.95 billion by 2023 from USD 3.63 billion in 2018, growing at a CAGR of 6.4% from 2018 to 2023. Key factors ...
Adventitious microorganisms—the bane of bioprocessing—may mingle with raw ingredients, light upon exterior surfaces, or settle into bioreactors. To deal with such organisms, bioprocessors need to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback